Cargando…
Correction: Use of biomaterials for sustained delivery for anti-VEGF to treat retinal diseases
Autores principales: | Seah, Ivan, Zhao, Xinxin, Lin, Qianyu, Liu, Zengping, Su, Steven Zheng Zhe, Yuen, Yew Sen, Hunziker, Walter, Lingam, Gopal, Loh, Xian Jun, Su, Xinyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468361/ https://www.ncbi.nlm.nih.gov/pubmed/32444861 http://dx.doi.org/10.1038/s41433-020-0980-3 |
Ejemplares similares
-
Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases
por: Seah, Ivan, et al.
Publicado: (2020) -
Polymeric biomaterials in the treatment of posterior segment diseases
por: Seah, Ivan, et al.
Publicado: (2022) -
A Pilot Study on MicroRNA Profile in Tear Fluid to Predict Response to Anti-VEGF Treatments for Diabetic Macular Edema
por: Chan, Hwei Wuen, et al.
Publicado: (2020) -
Revisiting the dangers of the coronavirus in the ophthalmology practice
por: Seah, Ivan, et al.
Publicado: (2020) -
cGMP-grade human iPSC-derived retinal photoreceptor precursor cells rescue cone photoreceptor damage in non-human primates
por: Lingam, Swathi, et al.
Publicado: (2021)